ValenTx Secures $22,000,000 Series B Round

  • Feed Type
  • Date
    9/8/2009
  • Company Name
    ValenTx
  • Mailing Address
    200 Homedale Rd Carpinteria, CA 93013
  • Company Description
    The company is developing less invasive treatments for morbid obesity.
  • Website
    http://www.valentx.com/
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $22,000,000
  • Transaction Round
    Series B
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor
    SV Life Sciences
  • Venture Investor
    EDF Ventures
  • Venture Investor
    Affinity Capital
  • Venture Investor
    Kaiser Permanente Ventures
  • Venture Investor
    Sapient Capital
  • Venture Investor
    Undisclosed

Next Post

Related Topics

Related Posts

Xconomy Events Across the Network

The Napa Summit 2013: New Rules for Growth

San Francisco · 6/3/13

More Xconomy Events

Xconomy’s Most Popular

  1. Henri Termeer on Startups, Drug Prices, Getting Older (Part 1)
  2. Venture Funding Slows as VC Industry Contracts, & Top 10 Deals List
  3. Xconomy Opens in Texas, Expanding Roundup of Innovation Across U.S.
  4. Do You Need an Extended Warranty? Do the Math, Says SquareTrade
  5. Life After PowerPoint: Prezi Zooms Ahead in Digital Storytelling

Xconomy on Demand

Did you miss something? Don't despair…

Xconomy offers a number of ways to subscribe for free!

Subscribe Now
IDG Tech Network
Protected by Mozy
Eventbrite - events made easy

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York, Boulder/Denver, Texas and beyond.

© 2007-2013, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Website development support from Andrew Koyfman with design support from Rob Hunter.